X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
hematology (21) 21
humans (21) 21
male (17) 17
female (14) 14
transplantation (13) 13
middle aged (12) 12
adult (10) 10
immunology (9) 9
mice (8) 8
oncology (8) 8
transplantation, homologous (8) 8
aged (7) 7
animals (7) 7
bone-marrow-transplantation (7) 7
diagnosis (7) 7
differentiation (7) 7
leukemia (7) 7
versus-host-disease (7) 7
acute myeloid leukemia (5) 5
adolescent (5) 5
apoptosis (5) 5
bortezomib (5) 5
graft vs host disease - immunology (5) 5
hematology, oncology and palliative medicine (5) 5
young adult (5) 5
bone marrow (4) 4
cell biology (4) 4
cell survival (4) 4
chronic disease (4) 4
dendritic cells (4) 4
graft vs host disease - drug therapy (4) 4
graft-versus-host disease (4) 4
hematopoietic stem cells (4) 4
immune system diseases (4) 4
mice, inbred c57bl (4) 4
multiple myeloma (4) 4
original (4) 4
pathology (4) 4
retrospective studies (4) 4
survival (4) 4
t-lymphocytes - immunology (4) 4
unrelated donors (4) 4
aml (3) 3
analysis (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
association (3) 3
blood (3) 3
boronic acids - pharmacology (3) 3
cell proliferation (3) 3
flow cytometry (3) 3
gene expression (3) 3
graft vs host disease - epidemiology (3) 3
graft vs host disease - pathology (3) 3
graft vs host disease - prevention & control (3) 3
health aspects (3) 3
hematologic neoplasms - therapy (3) 3
lymphocytes (3) 3
mesenchymal stem cell transplantation (3) 3
mesenchymal stromal cells - cytology (3) 3
mice, inbred balb c (3) 3
multiple-myeloma (3) 3
myelodysplastic syndrome (3) 3
phenotype (3) 3
prognostic-factors (3) 3
prospective studies (3) 3
pyrazines - pharmacology (3) 3
regulatory t-cells (3) 3
remission induction (3) 3
stem-cell transplantation (3) 3
therapy (3) 3
abridged index medicus (2) 2
activation (2) 2
aged, 80 and over (2) 2
allo-hsct (2) 2
apoptosis - drug effects (2) 2
biopsy (2) 2
bone marrow transplantation (2) 2
boronic acids - administration & dosage (2) 2
care and treatment (2) 2
cell & tissue engineering (2) 2
cell lineage (2) 2
cell selection (2) 2
cgvhd (2) 2
chemical and pharmacologic phenomena (2) 2
child (2) 2
child, preschool (2) 2
chronic gvhd (2) 2
clinical medicine (2) 2
clinical-trials (2) 2
combined modality therapy (2) 2
consensus development project (2) 2
corticosteroids (2) 2
criteria (2) 2
disease models, animal (2) 2
expansion (2) 2
expression (2) 2
follow-up studies (2) 2
gene deletion (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Hematology, ISSN 0939-5555, 3/2018, Volume 97, Issue 3, pp. 533 - 535
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 09/2018, Volume 9
The relevance of the immune system in cancer has long been studied. Autologous adoptive T cell therapies, based on the use of tumor infiltrating lymphocytes... 
tumor-specific T cells | acute myeloid leukemia | cell selection | T cell-tumor cell synapse | immunotherapy
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 474 - 482
The current study was designed to assess the safety and efficacy of bortezomib in combination with fludarabine and melphalan as reduced intensity conditioning... 
graft‐versus‐host disease | multiple myeloma | conditioning regimen | bortezomib | transplantation | Conditioning regimen | Graft-versus-host disease | Transplantation | Bortezomib | Multiple myeloma | DIAGNOSED MULTIPLE-MYELOMA | PROGNOSTIC-FACTORS | BONE-MARROW-TRANSPLANTATION | AUTOLOGOUS TRANSPLANTATION | VERSUS-HOST-DISEASE | CHEMOTHERAPEUTIC-AGENTS | PLUS DEXAMETHASONE | TERM-FOLLOW-UP | STEM-CELL TRANSPLANTATION | HEMATOLOGY | graft-versus-host disease | T-CELLS | Graft vs Host Disease - epidemiology | Peripheral Nervous System Diseases - chemically induced | Apoptosis - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Boronic Acids - adverse effects | Male | Transplantation, Autologous | Pyrazines - therapeutic use | Melphalan - therapeutic use | Boronic Acids - therapeutic use | Transplantation, Homologous | Protease Inhibitors - pharmacology | Multiple Myeloma - drug therapy | T-Lymphocyte Subsets - drug effects | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Maintenance Chemotherapy | Boronic Acids - administration & dosage | Transplantation Conditioning - methods | Protease Inhibitors - therapeutic use | Immunosuppressive Agents - pharmacology | Multiple Myeloma - surgery | Chemical and Drug Induced Liver Injury - etiology | Immunosuppressive Agents - administration & dosage | Hematologic Diseases - chemically induced | Reoperation | Combined Modality Therapy | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Drug Synergism | Cyclosporine - therapeutic use | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Immunosuppressive Agents - adverse effects | Vidarabine - administration & dosage | Pyrazines - pharmacology | Peripheral Blood Stem Cell Transplantation | Boronic Acids - pharmacology | Clinical trials | Product development | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2017, Volume 140, Issue 3, pp. 674 - 685
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 08/2019, Volume 25, Issue 15, pp. 4616 - 4623
Purpose: The biologically active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (vit D), has immunoregulatory properties via binding vitamin D receptor... 
SURVIVAL | DENDRITIC CELLS | ONCOLOGY | PROSTATE-CANCER | REGULATORY T-CELLS | D DEFICIENCY | RISK | D-3 | GENE POLYMORPHISMS | ASSOCIATION | EXPRESSION | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 10, pp. 1580 - 1585
Journal Article
Immunology, ISSN 0019-2805, 03/2015, Volume 144, Issue 3, pp. 395 - 404
Memory B cells ( MBC s) have a long lifespan compared with naive B cells ( NBC s), remaining viable for years. This could predispose them to suffer misbalances... 
cell disorders | longevity | B | cell survival | PATHWAYS | B-cell disorders | MAINTENANCE | LYMPHOPOIESIS | HEMATOPOIESIS | MICE | IMMUNOLOGY | AGE | Aged | B cells | Gene expression | Genes | Age | Original
Journal Article
Journal Article